BioSig Technologies, Inc Stock News

Here are some of the most awesome ways in which artificial intelligence is changing life as we know it today.

On March 31, 2020, the FDA created the Coronavirus Treatment Acceleration Program (CTAP), a special emergency program for possible therapies, using every available method to move new treatments to pat

Westport, CT, April 17, 2020 -- Information on the progress of our subsidiary ViralClear Pharmaceuticals and Vicromax(tm) – a broad-spectrum orally administered anti-viral.

The startup's CEO is a former Merck executive who previously led two life sciences companies in the Philadelphia suburbs.

BioSig Technologies (NASDAQ:BSGM) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Wednesday, Zacks.com reports. The firm currently has a

Viewray (NASDAQ:VRAY) and BioSig Technologies (NASDAQ:BSGM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their i

Gainers BioSig Technologies, Inc. (NASDAQ: BSGM) shares gained 42.4% to close at $5.14 on Friday. BioSig is expected to host telebriefing on development updates regarding...

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.69%

Gaming and Leisure Properties trading resumes GLPI

Sinclair Broadcast trading resumes SBGI

NASDAQ market internals summary $NSD

MGM Growth Properties participates in a conference call with JPMorgan MGP

Raytheon, Missile Defense Agency sign $2B Standard Missile-3 contract RTN

Cheesecake Factory put volume heavy and directionally bearish CAKE

NYSE market internals summary $NYE